Abrdn Life Sciences Investors (NYSE:HQL) Sees Significant Increase in Short Interest

Abrdn Life Sciences Investors (NYSE:HQL) saw a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 77,800 shares, a growth of 212.4% from the December 15th total of 24,900 shares. Based on an average trading volume of 93,900 shares, the days-to-cover ratio is currently 0.8 days.

Hedge Funds Weigh In On Abrdn Life Sciences Investors

Hedge funds have recently modified their holdings of the stock. Future Financial Wealth Managment LLC acquired a new stake in Abrdn Life Sciences Investors in the 3rd quarter valued at $30,000. Ashton Thomas Securities LLC acquired a new stake in shares of Abrdn Life Sciences Investors in the 3rd quarter valued at $148,000. Sanctuary Advisors LLC bought a new stake in shares of Abrdn Life Sciences Investors in the 2nd quarter worth about $154,000. Kapstone Financial Advisors LLC acquired a new stake in shares of Abrdn Life Sciences Investors during the 3rd quarter worth about $177,000. Finally, Stephens Inc. AR lifted its holdings in Abrdn Life Sciences Investors by 7.6% during the 3rd quarter. Stephens Inc. AR now owns 12,707 shares of the company’s stock valued at $192,000 after purchasing an additional 896 shares during the last quarter. 32.21% of the stock is owned by institutional investors and hedge funds.

Abrdn Life Sciences Investors Stock Up 1.5 %

HQL stock traded up $0.20 during midday trading on Wednesday, hitting $13.48. The stock had a trading volume of 143,765 shares, compared to its average volume of 127,424. The stock has a 50-day simple moving average of $13.94 and a 200 day simple moving average of $14.67. Abrdn Life Sciences Investors has a 52 week low of $12.76 and a 52 week high of $15.90.

Abrdn Life Sciences Investors Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 10th. Shareholders of record on Thursday, November 21st were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 14.84%. This is an increase from Abrdn Life Sciences Investors’s previous quarterly dividend of $0.49. The ex-dividend date was Thursday, November 21st.

About Abrdn Life Sciences Investors

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.